These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9569027)

  • 1. Stable reintroduction of wild-type P53 (MTmp53ts) causes the induction of apoptosis and neuroendocrine-like differentiation in human ductal pancreatic carcinoma cells.
    Lang D; Miknyoczki SJ; Huang L; Ruggeri BA
    Oncogene; 1998 Mar; 16(12):1593-602. PubMed ID: 9569027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable expression of temperature-sensitive p53: a suitable model to study wild-type p53 function in pancreatic carcinoma cells.
    Nuevemann D; Christgen M; Ungefroren H; Kalthoff H
    Oncol Rep; 2006 Sep; 16(3):575-9. PubMed ID: 16865258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells.
    Moretti F; Farsetti A; Soddu S; Misiti S; Crescenzi M; Filetti S; Andreoli M; Sacchi A; Pontecorvi A
    Oncogene; 1997 Feb; 14(6):729-40. PubMed ID: 9038381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells.
    Tamura T; Aoyama N; Saya H; Haga H; Futami S; Miyamoto M; Koh T; Ariyasu T; Tachi M; Kasuga M
    Oncogene; 1995 Nov; 11(10):1939-46. PubMed ID: 7478511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
    Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K
    Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic background determines the response to adenovirus-mediated wild-type p53 expression in pancreatic tumor cells.
    Cascalló M; Mercadé E; Capellà G; Lluís F; Fillat C; Gómez-Foix AM; Mazo A
    Cancer Gene Ther; 1999; 6(5):428-36. PubMed ID: 10505853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of adenovirus-mediated wild-type p53 expression on the growth of human pancreatic carcinoma cell line cells].
    Guo H; Liu T; Gao J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Oct; 20(5):345-50. PubMed ID: 11717990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct effects of various p53 mutants on differentiation and viability of human K562 leukemia cells.
    Kremenetskaya OS; Logacheva NP; Baryshnikov AY; Chumakov PM; Kopnin BP
    Oncol Res; 1997; 9(4):155-66. PubMed ID: 9268986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells.
    Kusumoto M; Ogawa T; Mizumoto K; Ueno H; Niiyama H; Sato N; Nakamura M; Tanaka M
    Clin Cancer Res; 1999 Aug; 5(8):2140-7. PubMed ID: 10473098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis but not G1 arrest by expression of the wild-type p53 gene in small cell lung carcinoma.
    Adachi J; Ookawa K; Shiseki M; Okazaki T; Tsuchida S; Morishita K; Yokota J
    Cell Growth Differ; 1996 Jul; 7(7):879-86. PubMed ID: 8809405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to p53-mediated growth arrest and apoptosis in Hep 3B hepatoma cells.
    Friedman SL; Shaulian E; Littlewood T; Resnitzky D; Oren M
    Oncogene; 1997 Jul; 15(1):63-70. PubMed ID: 9233778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of ponasterone A-inducible the wild-type p53 protein-expressing clones from HSC-1 cells, cell growth suppression by p53 expression and the suppression mechanism.
    Hori M; Suzuki K; Udono MU; Yamauchi M; Mine M; Watanabe M; Kondo S; Hozumi Y
    Arch Dermatol Res; 2009 Oct; 301(9):631-46. PubMed ID: 19009304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
    Tomaszewska R
    Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
    Ramondetta L; Mills GB; Burke TW; Wolf JK
    Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of senescence-like phenotype and loss of paclitaxel sensitivity after wild-type p53 gene transfection of p53-null human non-small cell lung cancer H358 cells.
    Ling YH; Zou Y; Perez-Soler R
    Anticancer Res; 2000; 20(2A):693-702. PubMed ID: 10810342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.
    Mirjolet JF; Barberi-Heyob M; Didelot C; Peyrat JP; Abecassis J; Millon R; Merlin JL
    Br J Cancer; 2000 Nov; 83(10):1380-6. PubMed ID: 11044365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of the tumor suppressor p53 and its mutant forms on the differentiation and viability of K562 leukemic cells].
    Kremenetskaia OS; Logacheva NP; Baryshnikov AIu; Chumakov PM; Kopnin BP
    Tsitologiia; 1996; 38(12):1280-93. PubMed ID: 9163103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant p53 mediated induction of cell cycle arrest and apoptosis at G1 phase by 9-hydroxyellipticine.
    Sugikawa E; Hosoi T; Yazaki N; Gamanuma M; Nakanishi N; Ohashi M
    Anticancer Res; 1999; 19(4B):3099-108. PubMed ID: 10652599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.